Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP

This is a randomized single center prospective study in phase 4 conducted through Qilu Hospital in affiliation with Shandong University. The focus of this study is to assess the efficacy and safety of glycyrrhetinic acid in synergy with high-dose pulse dexamethasone therapy for the treatment of adults with ITP who have a platelet count less than 30K microliters. Participants are required to be between the ages of 18-80 years with newly-diagnosed primary immune thrombocytopenia (ITP). Participants can expect to receive oral compound glycyrrhizin three times a day for a month in combination with high-dose dexamethasone (for four days) if assigned to the experimental group.



back to top

Charity NavigatorGuideStar Seal NORD Member BadgeTHSNA logo